Irritable Colon

9 registered clinical trials studyying Irritable Colon.

Status	Trial	Sponsor	Phase
Terminated	Sb-705498 Rectal Pain Study NCT00461682	GlaxoSmithKline	Phase 2
Completed	Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome NCT00385099	GlaxoSmithKline	Phase 2
Completed	Study to Assess the Effect Of Alosetron On Mucosal Blood Flow NCT00370032	GlaxoSmithKline	Phase 4
Completed	Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy NCT00376896	GlaxoSmithKline	Phase 1
Terminated	Colon Investigation - Factors Determining Choice of Procedure NCT00423345	Sykehuset Telemark	—
Completed	Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS) NCT00101985	GlaxoSmithKline	Phase 2
Completed	Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable NCT01855711	GlaxoSmithKline	Phase 2
Completed	Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy NCT00067457	GlaxoSmithKline	Phase 3
Completed	Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy NCT00067561	GlaxoSmithKline	Phase 3